JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

Published 2012 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 366, Issue 9, Pages 787-798
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2012-03-01
DOI
10.1056/nejmoa1110556

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.